Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea
· Delayed Price · Currency is KRW 7,540.00
-100.00 (-1.31%)
At close: Jun 26, 2025, 3:30 PM KST
Seoulin Bioscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 74,572 | 75,410 | 89,569 | 104,708 | 80,539 | 65,085 | Upgrade
|
Other Revenue | -0 | -0 | - | - | - | - | Upgrade
|
| 74,572 | 75,410 | 89,569 | 104,708 | 80,539 | 65,085 | Upgrade
| |
Revenue Growth (YoY) | -13.11% | -15.81% | -14.46% | 30.01% | 23.74% | 19.62% | Upgrade
|
Cost of Revenue | 55,847 | 56,450 | 69,699 | 80,417 | 59,469 | 48,569 | Upgrade
|
Gross Profit | 18,725 | 18,961 | 19,871 | 24,292 | 21,070 | 16,516 | Upgrade
|
Selling, General & Admin | 15,147 | 14,697 | 15,016 | 12,475 | 11,144 | 9,626 | Upgrade
|
Research & Development | 1,378 | 1,214 | 785.23 | 870.46 | 786.82 | 998.37 | Upgrade
|
Other Operating Expenses | 490.84 | 483.24 | 441.22 | 396.47 | 382.27 | 335.09 | Upgrade
|
Operating Expenses | 18,474 | 18,008 | 17,376 | 15,094 | 13,619 | 12,046 | Upgrade
|
Operating Income | 251.37 | 952.67 | 2,495 | 9,198 | 7,451 | 4,471 | Upgrade
|
Interest Expense | -177.55 | -329.7 | -2,482 | -2,287 | -224.55 | -18.66 | Upgrade
|
Interest & Investment Income | 854.09 | 996.22 | 2,051 | 1,637 | 303.78 | 253.7 | Upgrade
|
Earnings From Equity Investments | 79.86 | 88.53 | 85.1 | 121.01 | 114.5 | 89.12 | Upgrade
|
Currency Exchange Gain (Loss) | -40.88 | 10.01 | -308.95 | -63.7 | -178.86 | 144.62 | Upgrade
|
Other Non Operating Income (Expenses) | 526.93 | 666.37 | 3,441 | 3,808 | -397.15 | 724.33 | Upgrade
|
EBT Excluding Unusual Items | 1,494 | 2,384 | 5,280 | 12,413 | 7,069 | 5,664 | Upgrade
|
Gain (Loss) on Sale of Investments | 1,993 | 1,986 | -4,966 | 2,011 | 160.11 | 118.2 | Upgrade
|
Gain (Loss) on Sale of Assets | -13.69 | -13.69 | -31.42 | -1.06 | 14,153 | 0.27 | Upgrade
|
Asset Writedown | -152.6 | -152.6 | - | -393.03 | -1,044 | - | Upgrade
|
Other Unusual Items | -281.6 | -648.11 | -2,211 | - | - | - | Upgrade
|
Pretax Income | 3,038 | 3,556 | -1,929 | 14,029 | 20,338 | 5,782 | Upgrade
|
Income Tax Expense | 160.96 | 415.34 | 394.29 | 3,464 | 4,459 | 981.4 | Upgrade
|
Earnings From Continuing Operations | 2,878 | 3,140 | -2,323 | 10,565 | 15,879 | 4,801 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | 29.47 | -111.04 | - | Upgrade
|
Net Income to Company | 2,878 | 3,140 | -2,323 | 10,595 | 15,768 | 4,801 | Upgrade
|
Minority Interest in Earnings | -151.2 | -226.34 | 2,206 | -435.72 | -178.88 | 91.64 | Upgrade
|
Net Income | 2,726 | 2,914 | -117.55 | 10,159 | 15,589 | 4,893 | Upgrade
|
Net Income to Common | 2,726 | 2,914 | -117.55 | 10,159 | 15,589 | 4,893 | Upgrade
|
Net Income Growth | - | - | - | -34.84% | 218.64% | -44.93% | Upgrade
|
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 | Upgrade
|
Shares Outstanding (Diluted) | 9 | 9 | 9 | 11 | 9 | 9 | Upgrade
|
Shares Change (YoY) | -0.74% | -0.50% | -19.46% | 23.72% | -0.07% | -1.26% | Upgrade
|
EPS (Basic) | 313.75 | 334.30 | -13.42 | 1158.09 | 1773.24 | 556.14 | Upgrade
|
EPS (Diluted) | 313.44 | 334.08 | -13.42 | 798.15 | 1773.07 | 555.99 | Upgrade
|
EPS Growth | - | - | - | -54.98% | 218.90% | -44.22% | Upgrade
|
Free Cash Flow | -1,947 | -4,660 | -14.95 | -4,817 | 7,984 | 3,283 | Upgrade
|
Free Cash Flow Per Share | -224.01 | -534.60 | -1.71 | -442.90 | 908.19 | 373.19 | Upgrade
|
Dividend Per Share | 97.684 | 97.684 | - | - | - | - | Upgrade
|
Gross Margin | 25.11% | 25.14% | 22.18% | 23.20% | 26.16% | 25.38% | Upgrade
|
Operating Margin | 0.34% | 1.26% | 2.79% | 8.78% | 9.25% | 6.87% | Upgrade
|
Profit Margin | 3.66% | 3.86% | -0.13% | 9.70% | 19.36% | 7.52% | Upgrade
|
Free Cash Flow Margin | -2.61% | -6.18% | -0.02% | -4.60% | 9.91% | 5.04% | Upgrade
|
EBITDA | 1,590 | 2,318 | 3,781 | 10,215 | 9,381 | 6,455 | Upgrade
|
EBITDA Margin | 2.13% | 3.07% | 4.22% | 9.75% | 11.65% | 9.92% | Upgrade
|
D&A For EBITDA | 1,339 | 1,365 | 1,287 | 1,017 | 1,930 | 1,984 | Upgrade
|
EBIT | 251.37 | 952.67 | 2,495 | 9,198 | 7,451 | 4,471 | Upgrade
|
EBIT Margin | 0.34% | 1.26% | 2.79% | 8.78% | 9.25% | 6.87% | Upgrade
|
Effective Tax Rate | 5.30% | 11.68% | - | 24.69% | 21.92% | 16.97% | Upgrade
|
Advertising Expenses | - | 357.36 | 227.45 | 119.05 | 141.61 | 183.42 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.